Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Hookipa Pharma Inc (HOOK)

Hookipa Pharma Inc (HOOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead GlobeNewswire - Fri Oct 31, 7:00AM CDT

NEW YORK and VIENNA, Oct. 31, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (OTCID: HOOK, “HOOKIPA”) today announced the completion of the sale of its assets related to HOOKIPA’s HB-400 program...

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock GlobeNewswire - Fri Jul 18, 3:05PM CDT

NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for...

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV GlobeNewswire - Thu Jan 30, 6:00AM CST

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements GlobeNewswire - Tue Jan 7, 3:05PM CST

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates GlobeNewswire - Thu Nov 14, 2024

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker GlobeNewswire - Mon Nov 11, 2024

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024 GlobeNewswire - Thu Oct 31, 2024

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Doses First Patients with Eseba-vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer GlobeNewswire - Wed Oct 30, 2024

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma (NASDAQ: HOOK) Enters into Collaboration Deal with Roche to Develop HB-700 For KRAS-Mutated Cancers Spotlight Growth - Thu Oct 20, 2022

HOOKIPA Pharma, Inc. (NASDAQ: HOOK) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development

HOOK : 0.8750 (-0.93%)
HOOKIPA Pharma Reports Second Quarter 2022 Financial Results and Corporate Updates Globe Newswire - Thu Aug 11, 2022

HB-200 Phase 1 data presented at ASCO met all endpoints in heavily pre-treated head and neck cancer patients; Phase 2 study underwayUS Food and Drug...

HOOK : 0.8750 (-0.93%)

Barchart Exclusives

Is Ford a Dividend Stock Worth Buying for 2026 After Its 34% Rise This Year? Barchart - Tue Dec 30, 6:30PM CST
While Ford is up 34% for the year and has a healthy dividend yield of 4.5%, the stock's 2026 forecast does not look too bright. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot